FDA Gives Three Vouchers for Faster Psychedelic Approvals

The US has given three drugmakers accelerated pathways to approval for psychedelic medications with clinical trials underway.

The groups running trials include Compass Pathways, Transcend Therapeutics and the nonprofit Usona Institute, according to a person familiar with the matter.